Zealand Pharma has concluded enrolment for its global, randomised Phase IIb ZUPREME-1 trial, assessing the long-acting amylin ...
School is where our children learn vital socialisation skills, they learn to play and get along together. But a system that ...
Without additional capital funding, Edmonton Public Schools anticipates that enrolment growth will outpace the creation of ...
Hutchmed has concluded enrolment of its multi-centre Phase II trial of fanregratinib (HMPL-453), a treatment for intrahepatic ...